170 related articles for article (PubMed ID: 22783586)
1. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes.
Lin X; Tang X; Jiang Q; Liu Q; Lin Z; Lin J; Chen L; Hong H
Clin Lab; 2012; 58(5-6):539-44. PubMed ID: 22783586
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome.
Dong B; Ji W; Zhang Y
Intern Med; 2011; 50(10):1093-7. PubMed ID: 21576834
[TBL] [Abstract][Full Text] [Related]
3. Serum chemerin levels are associated with the presence and extent of coronary artery disease.
Xiaotao L; Xiaoxia Z; Yue X; Liye W
Coron Artery Dis; 2012 Sep; 23(6):412-6. PubMed ID: 22828724
[TBL] [Abstract][Full Text] [Related]
4. The association of serum chemerin level with risk of coronary artery disease in Chinese adults.
Yan Q; Zhang Y; Hong J; Gu W; Dai M; Shi J; Zhai Y; Wang W; Li X; Ning G
Endocrine; 2012 Apr; 41(2):281-8. PubMed ID: 22042485
[TBL] [Abstract][Full Text] [Related]
5. Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome.
Szpakowicz A; Szpakowicz M; Lapinska M; Paniczko M; Lawicki S; Raczkowski A; Kondraciuk M; Sawicka E; Chlabicz M; Kozuch M; Poludniewski M; Dobrzycki S; Kowalska I; Kaminski K
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439815
[TBL] [Abstract][Full Text] [Related]
6. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
[TBL] [Abstract][Full Text] [Related]
7. High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events - Insights from phenotype and genotype characterization.
Leiherer A; Muendlein A; Kinz E; Vonbank A; Rein P; Fraunberger P; Malin C; Saely CH; Drexel H
Vascul Pharmacol; 2016 Feb; 77():60-8. PubMed ID: 26304698
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].
Wang LY; Wei L; Yu HY; Zhang Y; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):235-8. PubMed ID: 19552838
[TBL] [Abstract][Full Text] [Related]
9. Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects.
Cheon DY; Kang JG; Lee SJ; Ihm SH; Lee EJ; Choi MG; Yoo HJ; Kim CS
Yonsei Med J; 2017 Mar; 58(2):319-325. PubMed ID: 28120562
[TBL] [Abstract][Full Text] [Related]
10. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio.
Yang M; Zhou X; Xu J; Yang B; Yu J; Gong Q; Zhang X; Sun X; Zhang Q; Xia J; Li J
Bosn J Basic Med Sci; 2019 Nov; 19(4):328-335. PubMed ID: 31078135
[TBL] [Abstract][Full Text] [Related]
11. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
Habib SS; Eshki A; AlTassan B; Fatani D; Helmi H; AlSaif S
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
[TBL] [Abstract][Full Text] [Related]
12. Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes.
Han J; Kim SH; Suh YJ; Lim HA; Shin H; Cho SG; Kim CW; Lee SY; Lee DH; Hong S; Kim YS; Nam MS
J Korean Med Sci; 2016 Jun; 31(6):924-31. PubMed ID: 27247502
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis.
Motawi TMK; Mahdy SG; El-Sawalhi MM; Ali EN; El-Telbany RFA
Can J Physiol Pharmacol; 2018 Jan; 96(1):38-44. PubMed ID: 28957639
[TBL] [Abstract][Full Text] [Related]
14. Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes.
Andersson DP; Laurencikiene J; Acosta JR; Rydén M; Arner P
J Clin Endocrinol Metab; 2016 Oct; 101(10):3765-3771. PubMed ID: 27501281
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism.
Takahashi M; Inomata S; Okimura Y; Iguchi G; Fukuoka H; Miyake K; Koga D; Akamatsu S; Kasuga M; Takahashi Y
Endocr J; 2013; 60(1):37-44. PubMed ID: 22986456
[TBL] [Abstract][Full Text] [Related]
16. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF
Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
[TBL] [Abstract][Full Text] [Related]
17. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
[TBL] [Abstract][Full Text] [Related]
18. Role of multifunctional Chemerin in obesity and preclinical diabetes.
Fatima SS; Butt Z; Bader N; Pathan AZ; Hussain S; Iqbal NT
Obes Res Clin Pract; 2015; 9(5):507-12. PubMed ID: 25666091
[TBL] [Abstract][Full Text] [Related]
19. Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.
Kim HM; Lee BW; Song YM; Kim WJ; Chang HJ; Choi DH; Yu HT; Kang E; Cha BS; Lee HC
Cardiovasc Diabetol; 2012 Jul; 11():84. PubMed ID: 22809439
[TBL] [Abstract][Full Text] [Related]
20. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
